NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Vesalius Cardiovascular

Vesalius Cardiovascular

Private
VancouverHealthcare & Life Scienceshttps://vesaliuscardio.com/

Last Round

Grant

May 4, 2023

Total Funding Raised

$61,000

Company Overview

Vesalius Cardiovascular is a medical device company that develops non-invasive transfemoral mitral valve repair solutions for the treatment of degenerative mitral regurgitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

transfemoral mitral valve repairTMVrmitral valve repairstructural heartcatheter-based surgeryminimally invasive cardiologychordal replacementannuloplastydegenerative mitral regurgitationinterventional cardiologymedical devicecath labheart valve replacementnon-surgical heart repair

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vesalius Cardiovascular Comparables

Compare Vesalius Cardiovascular with similar companies based on industry and business-model similarity.

Vesalius Cardiovascular comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CoreMedic
87%
NeoChord
83%
4C Medical Technologies, Inc.
82%

Vesalius Cardiovascular Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 4, 2023
GrantApr 1, 2020

Key People

Founding team and executive leadership

Peter Skarsgard

Co-Founder, Chief Medical Officer

Founding Team

Vincent LEDOUX

Chief Executive Officer

Executive Team

Vesalius Cardiovascular Investors

Notable investors and investment history

Vesalius Cardiovascular investors
InvestorRounds
Creative Destruction LabAccelerator
entrepreneurship@UBCAccelerator
National Research Council of CanadaGrant
HATCH Venture BuilderAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2020

    Received $43K from the National Research Council of Canada.

Vesalius Cardiovascular Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vesalius Cardiovascular Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vesalius Cardiovascular's valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver
Employee Range10
Year Founded2016
Last FundingMay 4, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.